These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33275066)

  • 1. Drug eluting implants in pharmaceutical development and clinical practice.
    Johnson AR; Forster SP; White D; Terife G; Lowinger M; Teller RS; Barrett SE
    Expert Opin Drug Deliv; 2021 May; 18(5):577-593. PubMed ID: 33275066
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthetic biodegradable polyesters for implantable controlled-release devices.
    Pothupitiya JU; Zheng C; Saltzman WM
    Expert Opin Drug Deliv; 2022 Oct; 19(10):1351-1364. PubMed ID: 36197839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug loaded implantable devices to treat cardiovascular disease.
    Adhami M; Martin NK; Maguire C; Courtenay AJ; Donnelly RF; Domínguez-Robles J; Larrañeta E
    Expert Opin Drug Deliv; 2023 Apr; 20(4):507-522. PubMed ID: 36924328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and approval of novel injectables: enhancing therapeutic innovations.
    Yadav P; Singh Y; Chauhan D; Yadav PK; Kedar AS; Tiwari AK; Shah AA; Gayen JR; Chourasia MK
    Expert Opin Drug Deliv; 2024 Apr; 21(4):639-662. PubMed ID: 38703363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in Polymeric Implants.
    Ahmed KK; Tamer MA; Ghareeb MM; Salem AK
    AAPS PharmSciTech; 2019 Sep; 20(7):300. PubMed ID: 31482251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-acting ocular drug delivery technologies with clinical precedent.
    O'Brien Laramy MN; Nagapudi K
    Expert Opin Drug Deliv; 2022 Oct; 19(10):1285-1301. PubMed ID: 35912841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The industrial design, translation, and development strategies for long-acting peptide delivery.
    Yang B; Gomes Dos Santos A; Puri S; Bak A; Zhou L
    Expert Opin Drug Deliv; 2022 Oct; 19(10):1233-1245. PubMed ID: 35787229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current manufacturing processes of drug-eluting sutures.
    Champeau M; Thomassin JM; Tassaing T; Jérôme C
    Expert Opin Drug Deliv; 2017 Nov; 14(11):1293-1303. PubMed ID: 28132527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Light-responsive in situ forming injectable implants for effective drug delivery to the posterior segment of the eye.
    Bisht R; Jaiswal JK; Chen YS; Jin J; Rupenthal ID
    Expert Opin Drug Deliv; 2016 Jul; 13(7):953-62. PubMed ID: 26967153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smart design of patient-centric long-acting products: from preclinical to marketed pipeline trends and opportunities.
    Bassand C; Villois A; Gianola L; Laue G; Ramazani F; Riebesehl B; Sanchez-Felix M; Sedo K; Ullrich T; Duvnjak Romic M
    Expert Opin Drug Deliv; 2022 Oct; 19(10):1265-1283. PubMed ID: 35877189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic applications of implantable drug delivery systems.
    Dash AK; Cudworth GC
    J Pharmacol Toxicol Methods; 1998 Jul; 40(1):1-12. PubMed ID: 9920528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current advances in sustained-release systems for parenteral drug delivery.
    Shi Y; Li LC
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1039-58. PubMed ID: 16296808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in polymeric microspheres for parenteral drug delivery--part 2.
    Mao S; Guo C; Shi Y; Li LC
    Expert Opin Drug Deliv; 2012 Oct; 9(10):1209-23. PubMed ID: 22924745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview on zein protein: a promising pharmaceutical excipient in drug delivery systems and tissue engineering.
    Labib G
    Expert Opin Drug Deliv; 2018 Jan; 15(1):65-75. PubMed ID: 28662354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local arterial wall drug delivery using balloon catheter system.
    Tesfamariam B
    J Control Release; 2016 Sep; 238():149-156. PubMed ID: 27473765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excipients with specialized functions for effective drug delivery.
    Hamman J; Steenekamp J
    Expert Opin Drug Deliv; 2012 Feb; 9(2):219-30. PubMed ID: 22196483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lyophilized liposome-based parenteral drug development: Reviewing complex product design strategies and current regulatory environments.
    Wang Y; Grainger DW
    Adv Drug Deliv Rev; 2019; 151-152():56-71. PubMed ID: 30898571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of freeze-drying in the development of oral drug delivery systems.
    Siow CR; Wan Sia Heng P; Chan LW
    Expert Opin Drug Deliv; 2016 Nov; 13(11):1595-1608. PubMed ID: 27267745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced fabrication approaches to controlled delivery systems for epilepsy treatment.
    van Tienderen GS; Berthel M; Yue Z; Cook M; Liu X; Beirne S; Wallace GG
    Expert Opin Drug Deliv; 2018 Sep; 15(9):915-925. PubMed ID: 30169981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.